Matches in Wikidata for { <http://www.wikidata.org/entity/Q63807294> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q63807294 description "assaig clínic" @default.
- Q63807294 description "clinical trial" @default.
- Q63807294 description "clinical trial" @default.
- Q63807294 description "clinical trial" @default.
- Q63807294 description "clinical trial" @default.
- Q63807294 description "ensaio clínico" @default.
- Q63807294 description "ensayo clínico" @default.
- Q63807294 description "ensayu clínicu" @default.
- Q63807294 description "essai clinique" @default.
- Q63807294 description "klinisch onderzoek" @default.
- Q63807294 description "клінічне випробування" @default.
- Q63807294 name "Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer" @default.
- Q63807294 type Item @default.
- Q63807294 label "Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer" @default.
- Q63807294 prefLabel "Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer" @default.
- Q63807294 P1132 Q63807294-B625CB5E-75B6-4B1D-80B7-2D62217AA1F9 @default.
- Q63807294 P1476 Q63807294-AEFBF54C-6000-4822-9197-7457A41845EE @default.
- Q63807294 P17 Q63807294-01D9C084-4BB2-4FAC-95B0-B55D986A07C0 @default.
- Q63807294 P17 Q63807294-18559184-DEB6-4E60-ABCA-269268DDA95E @default.
- Q63807294 P17 Q63807294-1A7D1091-8279-4506-9EB9-97D1FEC72141 @default.
- Q63807294 P17 Q63807294-48E113D6-2CB6-433F-AC6B-BCFB0212498B @default.
- Q63807294 P17 Q63807294-586CFB74-C269-4AEB-AF3E-8EB8ABA090DB @default.
- Q63807294 P17 Q63807294-87C6FE63-62DE-411D-BDB9-F990692FE7E9 @default.
- Q63807294 P17 Q63807294-9DEC52B7-1F4D-41D8-A1A3-DB3371F5F2BE @default.
- Q63807294 P17 Q63807294-A34D83DC-40DF-4BC1-B3E4-2D10D5C88786 @default.
- Q63807294 P17 Q63807294-C8359117-FDBB-4858-AF07-892CBCEAB4D1 @default.
- Q63807294 P17 Q63807294-CFAAA1C4-3E49-442A-A5FA-17F18770FB17 @default.
- Q63807294 P17 Q63807294-EF65F959-E403-4AB2-B0EC-011820AF6B19 @default.
- Q63807294 P1813 Q63807294-BC186F37-06AA-4685-A367-48BE4B127747 @default.
- Q63807294 P2899 Q63807294-3432C135-7E46-4D27-AD43-FAE0B51984FB @default.
- Q63807294 P3098 Q63807294-5B095D6E-150C-46E1-9FA6-6247BAB61FCB @default.
- Q63807294 P31 Q63807294-56A8577C-556A-49FB-A40F-81901F43D8F3 @default.
- Q63807294 P580 Q63807294-128BF723-292C-4B5A-B56D-5CFE4FF0EA72 @default.
- Q63807294 P582 Q63807294-9595CEAD-AFD9-4F65-943F-117AD6A84973 @default.
- Q63807294 P6099 Q63807294-B73B2C41-ACFC-4001-850A-211C570E0FBB @default.
- Q63807294 P8363 Q63807294-B2FF913D-F6EE-40BC-AEEE-598343242B53 @default.
- Q63807294 P859 Q63807294-C7ACA8BE-B5BF-491D-85EF-FB74610CD8A2 @default.
- Q63807294 P1132 "+488" @default.
- Q63807294 P1476 "A Randomized, Multi-Center Cross-Over Study to Evaluate Patient Preference and Health Care Professional (HCP) Satisfaction With Subcutaneous (SC) Administration of Trastuzumab in HER2-Positive Early Breast Cancer (EBC)" @default.
- Q63807294 P17 Q142 @default.
- Q63807294 P17 Q145 @default.
- Q63807294 P17 Q16 @default.
- Q63807294 P17 Q183 @default.
- Q63807294 P17 Q29 @default.
- Q63807294 P17 Q34 @default.
- Q63807294 P17 Q35 @default.
- Q63807294 P17 Q36 @default.
- Q63807294 P17 Q38 @default.
- Q63807294 P17 Q39 @default.
- Q63807294 P17 Q43 @default.
- Q63807294 P1813 "PrefHER" @default.
- Q63807294 P2899 "+18" @default.
- Q63807294 P3098 "NCT01401166" @default.
- Q63807294 P31 Q30612 @default.
- Q63807294 P580 "2011-10-01T00:00:00Z" @default.
- Q63807294 P582 "2013-05-01T00:00:00Z" @default.
- Q63807294 P6099 Q42824440 @default.
- Q63807294 P8363 Q78089383 @default.
- Q63807294 P859 Q212646 @default.